Hence, deciphering the molecular mechanisms of interaction between TRAP1 and its binding partners, called clients, and understanding how structural changes of TRAP1 influence its activity, are of paramount importance to clarify the biological outputs of TRAP1 engagement during tumor progression and other pathophysiological conditions characterized by changes in ROS levels. This evidence concerns the gene TRAP1 and neoplasm.